| MR编号 | AT/H/0872/001 | ||||||
|---|---|---|---|---|---|---|---|
| 药品名称 | Melerio 50 mg Powder and Solvent for Solution for Injection/Infusion | ||||||
| 活性成分 |
| ||||||
| 剂型 | Powder and solvent for solution for injection/infusion | ||||||
| 上市许可持有人 | ELC group s.r.o. Karolinska 650/1, Karlin 18600 Prague 8 Czech Republic | ||||||
| 参考成员国 - 产品名称 | Austria (AT) | ||||||
| 互认成员国 - 产品名称 |
| ||||||
| 许可日期 | 2021/06/23 | ||||||
| 最近更新日期 | 2021/07/14 | ||||||
| 药物ATC编码 |
申请类型 | 附件文件下载 | 市场状态 | Withdrawn（注：已撤市） | 撤市原因：2.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided could allow to conclude on a positive benefit-risk balance if the points for clarification identified were solved. |